Rapid Dose Therapeutics FY23 Revenue Declines 59%, Here Are The Details
Rapid Dose Therapeutics Corp. (OTCPK:RDTCF) (CSE: DOSE), released its financial results for the year ended February 28, 2023, revealing revenue of CA$718,298 ($542,000), a decrease of 59% compared to CA$1.75 million in FY 2022.
Fiscal Year 2023 Financial Highlights
